Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says leverages an “industry first” modular concept. Located in Tuas Biomedical Park, ...

Sanofi SAN-0.39%decrease; red down pointing triangle plans to spend about $1.05 billion building a new insulin manufacturing base in China, the French company’s largest single investment in the ...

Sanofi also boasts a separate manufacturing site in China’s capital of Beijing, plus production operations in the cities of Shenzhen and Hangzhou. The latest project marks the company’s ...

Sanofi plans to spend about $1.05 billion building a new insulin manufacturing base in China, the French company’s largest single investment in the world’s second-largest economy. The French ...

According to a company announcement on Friday ... already operates as a standalone business unit within Sanofi, manage 13 of its own manufacturing sites and four R&D centres.

SINGAPORE – A French pharmaceutical giant has opened a new $800 million manufacturing ... in Paris, Sanofi has operations in 100 countries and a global headcount of 91,000. The company ...

French drugmaker Sanofi (SASY.PA), opens new tab plans to change its policy on how it gives discounts to certain U.S. hospitals that serve low-income and uninsured patients, the company said on ...

Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal reports. The company said the investment will enhance the ...

U.S.-based vaccine maker Novavax said on Wednesday it will sell its manufacturing facility ... single investment in China, the company said on Monday. Sanofi announces its biggest China investment ...